Filter
155
Text search:
patent
Featured
Recommendations
17
New Publications
39
Language
Document type
No document type
72
Guidelines
30
Studies & Reports
29
Manuals
10
Strategic & Response Plan
6
Fact sheets
5
Training Material
2
Resource Platforms
1
Countries / Regions
Nigeria
13
India
8
Global
4
South Africa
3
Sierra Leone
2
Ethiopia
2
Ghana
2
Uganda
2
Nepal
2
Kenya
2
Rwanda
2
Malawi
2
Asia
2
Congo, Democratic Republic of
1
Cameroon
1
Zimbabwe
1
Philippines
1
Pakistan
1
Germany
1
Zambia
1
Bangladesh
1
Papua New Guinea
1
Sudan
1
Ukraine
1
Botswana
1
Lesotho
1
Myanmar / Burma
1
Western and Central Europe
1
Africa
1
Eastern Europe
1
Georgia
1
Authors & Publishers
Publication Years
Category
Countries
43
Clinical Guidelines
26
Women & Child Health
13
Public Health
8
Pharmacy & Technologies
6
Key Resources
5
Capacity Building
1
Toolboxes
HIV
22
COVID-19
13
Pharmacy
13
AMR
11
TB
9
Caregiver
8
Global Health Education
5
Mental Health
4
NTDs
4
Rapid Response
3
NCDs
2
Malaria
2
Disability
1
Ebola & Marburg
1
Conflict
1
Natural Hazards
1
Refugee
1
Zika
1
Specific Hazards
1
Planetary Health
1
Health Financing Toolbox
1
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these
...
Diese Broschüre möchte dazu beitragen, dass möglichst viele Menschen die Ergebnisse öffentlich finanzierter Forschung nutzen können.
Nurses at present are facing various personal, interpersonal, professional, institutional and socio cultural challenges in their professional performance. Dealing with these issues may not be always clear. The lack of one correct approach in addressing different conte
...
Drawing light from the pandemic: A new strategy for health and sustainable development (2021)
Available in English, French, German and Russian
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
This interagency report provides recommendations for assuring quality of medicines during key activities of country-level procurement agencies, namely prequalification of pharmaceutical products and manufacturers; purchase of pharmaceutical products; storage of pharmaceutical products; and distribut
...
UN, international agencies and experts released a groundbreaking report demanding immediate, coordinated and ambitious action to avert a potentially disastrous drug-resistance crisis.
If no action is taken - warns the UN Ad hoc Interagency Coordinating Group on Antimicrobial Resistance who release
...
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
Division of Tuberculosis Elimination.
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system of indicators that measure important aspects of a country’s pharmaceutical situation. Level 1 indicators measure the existence and
...
Severe Acute Malnutrition (SAM) is one of the greatest child survival challenges in the world today and
reportedly affects more than 16.2 million children each year1. High impact, proven treatment interventions exist
yet sadly approximately only 3.2 million children with SAM have access to treatme
...
The purpose of the landscape analysis is ultimately to facilitate improved engagement of private providers, thereby contributing to universal access to quality and affordable TB care and the end of the TB epidemic. It focuses on the role of private for-profit providers and on specific challenges and
...
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo
...
Cancer
recommended
This volume presents the complex patterns of cancer incidence and death around the world and evidence on effective and cost-effective ways to control cancers. The Disease Control Priorities Volume 3 evaluation of cancer will indicate where cancer treatment is ineffective and wasteful, and offer alte
...
Updated 10 August 2020
This document presents an essential medicines list (EML) to manage patients in intensive care units (ICUs) with suspected or confirmed COVID-19 diagnosis, which includes active ingredients with dosage form and concentration, and are preferably in the WHO Model Lists of Essent
...
Available in Arabic, Chinese, English, French, Russian and Spanish. You can download a summary of the main report and background documents!
The report demonstrates that the current system—at both national and international levels— was not adequate to protect people from COVID-19. The time it t
...
Audit Report
